Axogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Cover
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Intangible Assets, Net - Narrative (Details)

v3.21.2

Intangible Assets, Net - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Intangible assets
Amortization of intangible assets	$ 52	$ 39	$ 148	$ 111
Sales and Marketing Expense
Intangible assets
Royalty fees included in sales and marketing expense	$ 687	$ 701	$ 2,037	$ 1,635
License agreements
Intangible assets
Notice period for termination of license agreements			60 days
Minimum royalty of agreements			$ 13
Milestone fee upon receiving a Phase II Small Business Innovation Research			15
Milestone fee upon FDA approval			2
Milestone fee upon first commercial use of certain licensed technology			25
Milestone fee upon first use to manufacture products that utilize certain technology not currently incorporated into AxoGen products			$ 10
Minimum \| License agreements
Intangible assets
Amortization period of intangible assets			17 years
Royalty fees range under the license agreements			1.00%
Maximum \| License agreements
Intangible assets
Amortization period of intangible assets			20 years
Royalty fees range under the license agreements			3.00%
Royalty stack cap for royalties paid to more than one licensor for sales of the same product			3.75%
Maximum \| Patents
Intangible assets
Amortization period of intangible assets			20 years

- Definition

Represents the amount of milestone payment due if Axogen receives FDA approval of its Avance Nerve Graft.

+ References

No definition available.

+ Details

Name:	axgn_MilestonePaymentContingentUponFDApproval
Namespace Prefix:	axgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the amount of milestone payment due upon first commercial use of certain licensed technology to provide services to manufacture products for third parties.

+ References

No definition available.

+ Details

Name:	axgn_MilestonePaymentContingentUponFirstCommercialUseOfCertainLicensedTechnology
Namespace Prefix:	axgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the amount of milestone payment due upon first use to manufacture products that utilize certain technology that is not currently incorporated into AxoGen products.

+ References

No definition available.

+ Details

Name:	axgn_MilestonePaymentContingentUponFirstUseToManufactureProductsUtilizingCertainTechnology
Namespace Prefix:	axgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the amount of milestone payment due if the reporting entity receives a grant under one of the grants specified in the license agreement.

+ References

No definition available.

+ Details

Name:	axgn_MilestonePaymentContingentUponReceiptOfGrant
Namespace Prefix:	axgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Minimum quarterly royalty required under the terms of one of the reporting entity's licensing arrangements.

+ References

No definition available.

+ Details

Name:	axgn_MinimumRoyaltyOfLicenseAgreement
Namespace Prefix:	axgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Notice period for termination of license agreements.

+ References

No definition available.

+ Details

Name:	axgn_NoticePeriodForTerminationOfLicenseAgreements
Namespace Prefix:	axgn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The maximum percentage of royalty which may be paid for the sale of the same product, pursuant to a capping arrangement in the license agreements.

+ References

No definition available.

+ Details

Name:	axgn_PercentageOfCappingRoyaltiesForMultipleRoyaltyPaymentsToLicensors
Namespace Prefix:	axgn_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Royalty fees percentage under license agreements.

+ References

No definition available.

+ Details

Name:	axgn_RoyaltyFeesPercentageUnderLicenseAgreements
Namespace Prefix:	axgn_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

+ Details

Name:	us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 926
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

+ Details

Name:	us-gaap_RoyaltyExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: